FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial.

Alexandra PoinasMarie LemoigneSarah Le NaourJean-Michel NguyenSolène Schirr-BonnansValery-Pierre RicheFlorence VrignaudLaurent MachetJean-Paul ClaudelMarie-Thérèse LecciaEwa HainautNathalie BenetonCécile DertAurélie BoisrobertLaurent FletAnne ChiffoleauStéphane CorvecAmir KhammariBrigitte Dréno

Published in: Trials (2020)

ClinicalTrials.gov: NCT03334682. Registered on 7 November 2017.

Keyphrases

phase iii
double blind
phase ii
study protocol
clinical trial
placebo controlled
polycystic ovary syndrome
open label
pregnancy outcomes
randomized controlled trial
hidradenitis suppurativa
cervical cancer screening
breast cancer risk
pregnant women
metabolic syndrome
skeletal muscle